Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01392222 · ClinicalTrials.gov registry record
Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 21
- Enrollment target
NCT01392222: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01392222 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01392222 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to understand more about why some patients choose to have surgery to treat their papillary microcarcinoma (PMC) and others choose to have their papillary microcarcinoma (PMC) regularly watched by their doctor to see if and when they may need surgery (referred to as "active surveillance"). The investigators also hope learn more about what patients and their family members worry about or feel they will gain from surgery or active surveillance.
Interventions
- BEHAVIORAL Focus groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-06 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01392222
The ClinicalTrials.gov registry entry for NCT01392222 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Focus groups is the first listed.
NCT01392222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01392222 about?
NCT01392222 is a clinical study titled "Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others". The purpose of this study is to understand more about why some patients choose to have surgery to treat their papillary microcarcinoma (PMC) and others choose to have their papillary microcarcinoma (PMC) regularly watched by their doctor to see if and when they may need surgery (referred to as "acti...
What is the current status of trial NCT01392222?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2011-06. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01392222?
The interventions under investigation include: Focus groups (BEHAVIORAL).
Who is sponsoring clinical trial NCT01392222?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.